PGEN
Precigen Inc

8,904
Mkt Cap
$1.16B
Volume
2.8M
52W High
$5.47
52W Low
$1.11
PE Ratio
-2.51
PGEN Fundamentals
Price
$3.51
Prev Close
$3.28
Open
$3.32
50D MA
$4.27
Beta
1.87
Avg. Volume
4.62M
EPS (Annual)
-$0.4715
P/B
29.66
Rev/Employee
$27,447.55
$235.66
Loading...
Loading...
News
all
press releases
Precigen (NASDAQ:PGEN) Stock Price Up 7.5% - Should You Buy?
Precigen (NASDAQ:PGEN) Shares Up 7.5% - Here's Why...
MarketBeat·19h ago
News Placeholder
More News
News Placeholder
Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates
Precision BioSciences (DTIL) delivered earnings and revenue surprises of +271.43% and +178.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
Precigen (NASDAQ:PGEN) Upgraded at Zacks Research
Zacks Research raised shares of Precigen from a "strong sell" rating to a "hold" rating in a research note on Tuesday...
MarketBeat·2d ago
News Placeholder
Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates
Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of -19.72% and +14.87%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 PR...
PR Newswire·3d ago
News Placeholder
Precigen (PGEN) to Release Quarterly Earnings on Wednesday
Precigen (NASDAQ:PGEN) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 18. (View Earnings Report at...
MarketBeat·3d ago
News Placeholder
CorMedix (CRMD) Lags Q4 Earnings Estimates
CorMedix (CRMD) delivered earnings and revenue surprises of -29.07% and +1.03%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Lansing Street Advisors Takes $1.80 Million Position in Precigen, Inc. $PGEN
Lansing Street Advisors purchased a new position in Precigen, Inc. (NASDAQ:PGEN - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·15d ago
News Placeholder
Precigen (NASDAQ:PGEN) Share Price Passes Below Two Hundred Day Moving Average - What's Next?
Precigen (NASDAQ:PGEN) Stock Crosses Below 200 Day Moving Average - Should You Sell...
MarketBeat·15d ago
News Placeholder
Precigen (NASDAQ:PGEN) Shares Down 6% - What's Next?
Precigen (NASDAQ:PGEN) Trading Down 6% - Should You Sell...
MarketBeat·23d ago
<
1
2
...
>

Latest PGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.